Obsessive-Compulsive Disorder Cognitive Behavior Therapy

J Gordon Millichap

doi:10.15844/pedneurbriefs-25-10-10

Obsessive-Compulsive Disorder Cognitive Behavior Therapy

Pediatric Neurology Briefs

Volume 25 (2011): Issue 10

By: J Gordon Millichap

Open Access

|Oct 2011

Abstract

Researchers at University of Pennsylvania School of Medicine, Duke University, Brown, Michigan, and University of Massachusetts, Worcester, as members of the Pediatric-OCD Treatment Study II (POTS II) Randomized Controlled Trial, examined effects of augmenting serotonin reuptake inhibitor (SRI) treatment with short-term cognitive behavior therapy (CBT) in 124 pediatric outpatients, 7 to 17 years of age, with a primary diagnosis of OCD.

References

Franklin ME Sapyta J Freeman JB Khanna M Compton S Almirall D Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial JAMA 2011 Sep 21 306 11 1224 1232 10.1001/jama.2011.1344 21934055
Open DOI Search in Google Scholar Back to article
O’Rourke JA Scharf JM Platko J Stewart SE Illmann C Geller DA The familial association of tourette’s disorder and ADHD: the impact of OCD symptoms Am J Med Genet B Neuropsychiatr Genet 2011 Jul 156B 5 553 560 10.1002/ajmg.b.31195 21557467
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-25-10-10 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 79 - 80

Published on: Oct 1, 2011

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Serotonin Reuptake Inhibitor,

Cognitive Behavior Therapy,

Medication Plus Instruction

© 2011 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 25 (2011): Issue 10